The Swiss Times - Swiss News in English

Swiss terrorism plot foiled

  • By Paige Baschuk
  • 24 June 2022

How Russian oligarchs may be laundering money through Switzerland, Swiss scientist wins award for cancer vaccine, and more in our roundup of Swiss news from June 21 – 24.

Swiss terrorism plot foiled

There is a mystery surrounding three tons of gold which arrived from Russia in May.

Who in Switzerland ordered Russian gold?

More than three tons of gold worth more than $200 million were shipped from Russia to Switzerland this May, according to multiple reports this week. The shipment was made two months after Switzerland announced tough sanctions on Russia, amid its invasion of Ukraine and provocation of war. All four Swiss gold refineries deny having ordered the shipment or any other involvement. Moreover, the Swiss Association of Manufacturers and Traders of Precious Metals also confirmed none of its members are involved in the illegal import. The gold could be used by a Russian oligarch for money laundering, according to Marc Ummel, a raw materials expert at Swissaid. Ummel advises that the State Secretariat for Economic Affairs investigate and report to the public what is going on. Read more.

Amid war, Switzerland pushed to define neutrality

Swiss men detained for bombing plan

German police arrested two Swiss citizens this week on the suspicion that the men were planning to bomb a major Swiss city, according to Baden-Württemberg prosecutors. The two young men, ages 24 and 26, have been under investigation since the beginning of June after stating their intentions to buy explosives on the dark web. The men traveled to Stuttgart to buy the explosives. The fight against such terrorism involves international cooperation, according to André Duvillard, a representative of the Swiss Security Network (SSN). Read more.

Swiss scientist invents cancer vaccine, wins prize

Swiss biotechnologist Madiha Derouazi and French immunologist Elodie Benoue this week were awarded the European Inventor Award from the European Patent Office (EPO) for a vaccine that could be used to treat different types of cancer. The vaccine boosts the immune system’s response to fighting cancer, said the EPO. Their vaccine assembly invention, known as the KISMA platform, is “intended for use alongside treatments such as surgery, chemotherapy and radiotherapy,” the EPO said. KISMA has been used in colorectal cancer trials and now other human trials are underway. Read More.

This article may be freely shared and re-printed, provided that it prominently links back to the original article. 

Most Read

Sunday, April 7 – Round Up

7 April 2024
Sunday, April 7 – Round Up
Switzerland may fund French nuclear projects as it grapples with internal issues in the news this Sunday morning.

Swiss Employers Association: Increase Retirement Ages

8 April 2024
Swiss Employers Association: Increase Retirement Ages
Following the rejection of a pension initiative, the Swiss Employers' Association (SAV) recommends a gradual raise in retirement age to 66.

Diehl Defence Will Develop Drones For Swiss Defence Firm Skysec

12 April 2024
Diehl Defence Will Develop Drones For Swiss Defence Firm Skysec
Diehl Defence collaborates with Skysec Defence under a new agreement to enhance drone defense capabilities for military use.

Zurich VC Lakestar Secures $600 Million In New Funds

12 April 2024
Zurich VC Lakestar Secures $600 Million In New Funds
Lakestar successfully closes two new funds, accumulating $600 million, to advance Europe's digital sovereignty.

Stay in Touch!

Noteworthy

Thai Central Group to Allegedly Takeover KaDeWe
Thai Central Group to Allegedly Takeover KaDeWe
12 April 2024
Leonteq and Raiffeisen Extend Partnership
Leonteq and Raiffeisen Extend Partnership
12 April 2024